Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription profiling of human breast cancer cell lines (23)

ABSTRACT: Transcriptional profiling was conducted on RNA from 23 breast cancer cell lines to identify genes whose expression level correlates with sensitivity of particular drug Experiment Overall Design: Baseline gene expression profiling was performed using 23 breast cancer cell lines to identify genomic signatures highly correlated with in vitro sensitivity to a particular drug

ORGANISM(S): Homo sapiens

SUBMITTER: Huang F

PROVIDER: S-ECPF-GEOD-6569 | biostudies-other | 2007 Mar

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Transcription profiling of human breast cancer cell lines

Project description:Total RNA from 46 breast cell lines was labelled using the Illumina TotalPrep RNA Amplification kit (Ambion) following manufacturer's instructions. 1.5 µg of biotin-labelled cRNA were used for each hybridisation on Sentrix Human-6 v1 BeadChips (Illumina, San Diego, CA) following manufacturer's protocol.

| S-ECPF-TABM-827 | biostudies-other

Transcription profiling of human growing breast cancer cell lines

Project description:Gene expression analysis on growing breast cancer cell lines. Experiment Overall Design: see Bild, A. et.al.

| S-ECPF-GEOD-3156 | biostudies-other

Transcription profiling of 51 human breast cancer cell lines

Project description:A cell line comparison experiment for breat cancer 51 cancer cell lines

| S-ECPF-MTAB-7 | biostudies-other

Transcription profiling of 51 human breast cancer cell lines

Project description:We measured baseline gene expression profiles for a panel of 51 breast cancer cell lines using the Affymetrix U133A array.

| S-ECPF-TABM-157 | biostudies-other

Transcription profiling of human breast cancer cell lines to investigate p53 status in breast cancer

Project description:Breast cancer subtypes identified in genomic studies have different underlying genetic defects. Mutations in the tumor suppressor p53 occur more frequently in estrogen receptor (ER) negative, basal-like and HER2-amplified tumors than in luminal, ER positive tumors. Thus, because p53 mutation status is tightly linked to other characteristics of prognostic importance, it is difficult to identify p53's independent prognostic effects. The relation between p53 status and subtype can be better studied by combining data from primary tumors with data from isogenic cell line pairs (with and without p53 function). In this study, the p53-dependent gene expression signatures of four cell lines (MCF-7, ZR-75-1, and two immortalized human mammary epithelial cell lines) were identified by comparing p53-RNAi transduced cell lines to their parent cell lines. Cell lines were treated with vehicle only or doxorubicin to identify p53 responses in both non-induced and induced states. Each cell line displayed unique patterns of gene expression, but cell type specific trends were evident. A common gene expression signature associated with p53 loss across all four cell lines was identified. This signature showed overlap with the signature of p53 loss in primary breast tumors and predicted relapse-free survival and overall survival in independent test data sets. Experiment Overall Design: We analyzed 48 arrays performed using 48 polyA RNA samples. RNAs were collected from cell lines treated with an IC50 dose of doxorubicin hydrochloride or with a feeding control. Each cell line had its own reference which represented the second sample on the dual channel array. These untreated RNAs were prepared by pooling four harvests of that cell line at 60-80% confluence and 48h after feeding

| S-ECPF-GEOD-3178 | biostudies-other

Transcription profiling of human cancer cell lines

Project description:We describe a novel approach combining RNAi screening in multiple cell lines with expression profiling to identify novel cancer targets in breast cancer cell lines

| S-ECPF-TABM-610 | biostudies-other

Transcription profiling of medullary breast cancer vs ductal breast cancer cell lines

Project description:Gene expression analysis of meduallary breast cancer vs ductal breast cancer

| S-ECPF-MEXP-441 | biostudies-other

Transcription profiling of human breast cancer cell lines (23)

Project description:Transcriptional profiling was conducted on RNA from 23 breast cancer cell lines to identify genes whose expression level correlates with sensitivity of particular drug Experiment Overall Design: Baseline gene expression profiling was performed using 23 breast cancer cell lines to identify genomic signatures highly correlated with in vitro sensitivity to a particular drug

2008-06-15 | E-GEOD-6569 | biostudies-arrayexpress

Transcription profiling by array of human breast cancer cell lines treated with fulvestrant

Project description:A significant fraction of breast cancers exhibit de novo or acquired resistance to estrogen deprivation. To model resistance to aromatase inhibitor (AI) therapy, long-term estrogen-deprived (LTED) derivatives of MCF-7 and HCC-1428 cells were generated through culture for 3 and 7 months under hormone-depleted conditions, respectively. These LTED cells showed sensitivity to the ER downregulator fulvestrant under hormone-depleted conditions, suggesting continued dependence upon ER signaling for hormone-independent growth. To evaluate the role of ER in hormone-independent growth, LTED cells were treated +/- 1 uM fulvestrant x 48 h before RNA was harvested for gene expression analysis. MCF-7/LTED and HCC-1428/LTED cells were treated with 10% DCC-FBS with or without the estrogen receptor antagonist drug fulvestrant for 48 hrs prior to RNA harvest for array analysis. Three replicates per condition.

| S-ECPF-GEOD-22533 | biostudies-other

Transcription profiling of human breast cancer cell lines treated with dasatinib and herceptin

Project description:effect on gene expression with the treatment of dasatinib and herceptin on breast cancer cell lines

| S-ECPF-MEXP-2065 | biostudies-other